Literature DB >> 17650376

Far-infrared spectroscopic characterization of explosives for security applications using broadband terahertz time-domain spectroscopy.

W H Fan1, A Burnett, P C Upadhya, J Cunningham, E H Linfield, A G Davies.   

Abstract

Broadband terahertz time-domain spectroscopy (THz-TDS) has been used to measure the far-infrared (FIR) vibrational spectra of several commonly used pure explosives, including 2,4,6-trinitrotoluene (TNT), 1,3,5-trinitroperhydro-1,3,5-triazine (RDX), 1,3-dinitrato-2,2-bis(nitratomethyl)propane (PETN), and two types of plastic explosive, SEMTEX and SX2. A number of distinct absorption peaks, originating from FIR-active vibrational modes of these polycrystalline energetic materials, were observed in the frequency range 0.3-7.5 THz (10-250 cm(-1)). In addition, the temperature-dependent FIR vibrational spectra of PETN were measured between 4 K and 296 K with several well-resolved absorption peaks observed across this temperature range. We find that as the temperature is reduced, the observed absorption peaks resolve into narrower features and shift towards higher frequencies. The temperature dependence of the spectra is explained in terms of the anharmonicity of the vibrational potentials of crystalline compounds, and an empirical fit is given to describe the peak shift with temperature.

Entities:  

Year:  2007        PMID: 17650376     DOI: 10.1366/000370207781269701

Source DB:  PubMed          Journal:  Appl Spectrosc        ISSN: 0003-7028            Impact factor:   2.388


  3 in total

1.  First principles investigation of L-alanine in terahertz region.

Authors:  Zhuan-Ping Zheng; Wen-Hui Fan
Journal:  J Biol Phys       Date:  2012-02-10       Impact factor: 1.365

2.  Selective Phonon Stimulation Mechanism to Tune Thermal Transport.

Authors:  Gaurav Kumar; Peter W Chung
Journal:  ACS Omega       Date:  2022-04-07

3.  Low-Frequency Vibrational Spectroscopy and Quantum Mechanical Simulations of the Crystalline Polymorphs of the Antiviral Drug Ribavirin.

Authors:  Margaret P Davis; Timothy M Korter
Journal:  Mol Pharm       Date:  2022-08-11       Impact factor: 5.364

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.